Post PCI bleeding can cause kidney injury

Original title: Impact of Periprocedural Bleeding on Incidente of Constrast-Induced Acute Kidney Injury in patients treated with Percutaneous Coronary Intervention. Reference: Yohei Ohno, et al. J Am Coll Cardiol 2013;62:1260-6

Contrast induced acute kidney injury (CI-AKI) is a serious complication associated to higher morbimortality rates and higher costs, but its correlation to bleeding remains controversial. This study included 2646 patients undergoing PCI; 315 (12%) presented CI AKI. 

Patients were divided in 5 groups according to hemoglobin variation after PCI (Hb): Group A showed no change in Hb levels (290 patients), B: a decrease in Hb 3 g/dl (244 patients). There were no differences in baseline characteristics between the groups.

Kidney injury was associated to cardiac insufficiency CF III or IV, infarction with ST segment elevation, as well as a greater decrease in HB levels (odds ratio 2.23, IC 95% 1.37 to 3.63 p=0.001). CI-AKI patients presented higher rates of mortality compared to stable patients, as well as a composite of heart failure, cardiogenic shock, death, major bleeding and need of transfusion.

There was a significative correlation between HB level decrease and the events rate that, globally, resulted in 12%. Each group separately showed different rates:  A 6%, B 8%, C 11%, D 17% y E 26% (p<0.001). Minor bleeding did not have significant impact.

Conclusion:

Periprocedural bleeding was significantly associated with CI-AKI, with CI-AKI incidence correlating with bleeding severity. These patients presented high risk of in-hospital mortality.

Comment:

It is known that kidney injury is a marker of bad evolution. This analysis also shows that bleeding may cause kidney injury after PCI and, in addition, it marks a bad evolution. It is important to remember the transradial approach reduces major bleeding events and, hence, should be the first choice not only for PC interventions but also for catheterizations.

Courtesy of Dr Carlos Fava,
Interventional cardiologist
Favaloro Foundation
Buenos Aires – Argentina 

Dr. Carlos Fava para SOLACI.ORG

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroSMR Registry: Edge-to-Edge Mitral Treatment with 5-Year Outcomes

Cardiomyopathies and left atrial enlargement can lead to secondary mitral regurgitation (SMR). This condition is associated with ventricular dysfunction, causing heart failure, hospitalization, and...

TricValve Transcatheter Bicaval Valve System for Severe Tricuspid Insufficiency: Events at One Year

TricValve is the first bicaval valve system to obtain CE-Mark approval. This device heterotopic device eliminates tricuspid insufficiency reflux into the venous system, reducing...

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...